This website uses cookies to improve your user experience.
By using the site, you agree to our use of cookies.
Click here for more information about how we use cookies.
The congress will bring together experts in the field of basic and clinical oncology as well as molecular pathology to discuss current issues in cancer treatment decision-making, limitations of diagnostic tools and explore technological solutions to resolve cancer heterogeneity. Considering the previous experience in Verona in 2016, we expect stimulating discussion thanks to the high-level scientific debate and the standing of internationally renowned speakers and attendees.